Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Efficacy and Safety of Transcleral Lutein Iontophoresis in Patients With Intermediate Amd and Reticular Pseudodrusen: a Retrospective Study

NCT07420361 is registered in ClinicalTrials.gov with Mario Damiano Toro as lead sponsor.

NCT NCT07420361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07420361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Efficacy and Safety of Transcleral Lutein Iontophoresis in Patients With Intermediate Amd and Reticular Pseudodrusen: a Retrospective Study
Lead sponsor
Mario Damiano Toro
Phase
Observational
Overall status
Completed
Start date
August 1, 2023
Completion date
August 31, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate age-related macular degeneration with reticular pseudodrusen